Administering zinc to covid-19 patients could help towards their recovery

Mortality in this patient group was 21% compared to 5% of those with higher levels of zinc in the blood

Newswise — Administering zinc supplements to covid-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time. At the same time, it could help to prevent risk groups, like the elderly, from suffering the worst effects of the disease. These are the findings of a study by physicians and researchers from the Hospital del Mar, Hospital del Mar Medical Research Institute (IMIM) and Pompeu Fabra University (UPF), led by Dr. Robert Güerri, a physician at the Infectious Diseases Service of Hospital del Mar, which has just been published in the journal Nutrients.

The study analysed the zinc levels of 249 adult patients treated at the centre between 9 March and 1 April 2020, with an average age of 65 years. The most common symptoms presented at the time of admission were fever, cough and dyspnea. In all cases, they analysed their blood zinc levels, considering those under 50 μ/dl as being low. As explained by Dr. Güerri, first author of the clinical study, they analysed this parameter because "zinc is an essential element for maintaining a variety of biological processes, and altering its levels causes increased susceptibility to infections and increased inflammatory response". For this reason, "given the comorbidities associated with zinc deficiency and its immunomodulatory and antiviral actions, zinc levels and zinc supplementation may prove useful tools to tackle the covid-19 crisis".

Higher mortality in patients with lower zinc levels

1 in 4 patients had low levels of zinc. This group had more severe symptoms and higher levels of inflammation as measured by two markers, C-reactive protein (CRP) and interleukin 6 (IL-6), which mediate the inflammatory response. On average, their length of hospital stay was three times longer than patients with higher levels of zinc (25 days compared to 8).

Regarding mortality, zinc levels were significantly higher in patients who survived the infection, 62 μ/dl, versus 49 μ/dl for those who died. Moreover, 1 in 5 patients with low zinc levels died. Conversely, the mortality rate of those presenting higher levels upon admission was 5%. The study reveals that a one-unit increase of zinc in blood plasma is directly linked to a 7% reduction of the risk of dying from covid-19. Dr. Güerri highlights that "we have shown the importance of zinc levels in patients' blood as an additional predictor of outcome in covid-19, as well as its potential as a therapeutic tool for treatment. We therefore propose this variable as a new parameter to predict the evolution of patients and we propose initiating clinical trials concerning zinc supplementation in patients with low levels admitted for covid-19 and implementing programmes to administer supplements to groups at risk of having low zinc levels to reduce the effects of the pandemic".

Effect of zinc on the replication of the coronavirus

The study involved the collaboration of the groups of Dr. Rubén Vicente and Dr. Juana Díez at UPF. Their efforts, using in vitro techniques, have focused on studying in parallel the effects of zinc levels on the virus's capacity to expand. The results confirm that the poor prognosis in patients with low concentrations of zinc is due both to the effect that a lack of zinc has on immune imbalance and the increase in viral load, as they found that low levels of zinc enhance the expansion of the virus in infected cells.

At the same time, the results indicate that an element must be sought to enable enhancing the activity of zinc in the cell to block viral replication, as their studies have shown that contrary to what had been speculated at the onset of the pandemic, chloroquine cannot perform this function.

###

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 5391
Released: 13-Apr-2021 4:05 PM EDT
B.1.1.7. variant more transmissible, does not increase severity, Lancet studies suggest
Lancet

An observational study of patients in London hospitals suggests that the B.1.1.7. variant is not associated with more severe illness and death, but appears to lead to higher viral load, consistent with emerging evidence that this lineage is more transmissible than the original COVID-19 strain.

Newswise: Plasma device designed for consumers can quickly disinfect surfaces
Released: 13-Apr-2021 3:05 PM EDT
Plasma device designed for consumers can quickly disinfect surfaces
Princeton Plasma Physics Laboratory

The COVID-19 pandemic has cast a harsh light on the urgent need for quick and easy techniques to sanitize and disinfect everyday high-touch objects such as doorknobs, pens, pencils, and personal protective gear worn to keep infections from spreading.

Newswise: Narratives Can Help Science Counter Misinformation on Vaccines
Released: 13-Apr-2021 12:50 PM EDT
Narratives Can Help Science Counter Misinformation on Vaccines
Iowa State University

Narratives are a powerful tool that can help explain complex issues, but they can also serve as sources of misinformation, which presents a challenge as public health agencies work to educate people about COVID-19 vaccine.

Released: 13-Apr-2021 10:05 AM EDT
Puerto Rico, Coronavirus Among Top Latino Twitter Topics During 2020 Election
George Washington University

Latinos discussed Puerto Rico and the COVID-19 pandemic more than any other subject on Twitter in the run-up to the 2020 election, according to researchers at the George Washington University. Spanish-language tweets mentioning “freedom” and “socialism” were also popular, while topics such as Obamacare and immigration did not gain much traction.

Newswise: Americans continue struggling for a good night’s sleep during the pandemic
Released: 13-Apr-2021 9:00 AM EDT
Americans continue struggling for a good night’s sleep during the pandemic
American Academy of Sleep Medicine (AASM)

The coronavirus pandemic continues to have a negative impact on our sleep, according to new findings from the American Academy of Sleep Medicine.

Newswise:Video Embedded the-science-behind-the-shot-biotech-tools-developed-at-brookhaven-lab-fundamental-to-making-covid-19-vaccines
VIDEO
Released: 13-Apr-2021 8:05 AM EDT
The Science Behind the Shot: Biotech Tools Developed at Brookhaven Lab Fundamental to Making COVID-19 Vaccines
Brookhaven National Laboratory

You’ve probably heard that the first two vaccines approved for battling COVID-19 in the United States use a relatively new approach—injections of simple packets containing mRNA, a genetic material that instructs our cells to make coronavirus spike proteins. But the technology for generating sufficient amounts of those mRNA packets dates back to the 1980s, when F. William Studier, then a senior biophysicist at the U.S. Department of Energy’s Brookhaven National Laboratory, developed a way to harness the molecular machinery of a very different virus.

Newswise: UCLA Fielding School of Public Health Scholar’s Work on Fatigue and Health Published
Released: 13-Apr-2021 4:05 AM EDT
UCLA Fielding School of Public Health Scholar’s Work on Fatigue and Health Published
UCLA Fielding School of Public Health

A landmark work has been published examining fatigue as a hugely important factor in human health and extremely relevant to those with “long-haul” COVID-19 symptoms.

access_time Embargo lifts in 2 days
Embargo will expire: 14-Apr-2021 2:00 PM EDT Released to reporters: 12-Apr-2021 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Apr-2021 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 5391

close
1.06126